451 related articles for article (PubMed ID: 19207823)
41. Role of the orexinergic system in acute haemorrhage in the rat.
Hirota K; Kushikata T; Yoshida H; Kudo M; Kudo T
Neurosci Lett; 2008 Feb; 432(2):162-6. PubMed ID: 18187260
[TBL] [Abstract][Full Text] [Related]
42. The effect of orexins on intestinal motility in vitro in fed and fasted rats.
Korczynski W; Ceregrzyn M; Kato I; Wolinski J; Zabielski R
J Physiol Pharmacol; 2006 Nov; 57 Suppl 6():43-54. PubMed ID: 17228086
[TBL] [Abstract][Full Text] [Related]
43. Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo.
Wayner MJ; Armstrong DL; Phelix CF; Oomura Y
Peptides; 2004 Jun; 25(6):991-6. PubMed ID: 15203246
[TBL] [Abstract][Full Text] [Related]
44. Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex.
Karteris E; Machado RJ; Chen J; Zervou S; Hillhouse EW; Randeva HS
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1089-100. PubMed ID: 15687100
[TBL] [Abstract][Full Text] [Related]
45. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats.
Rodgers RJ; Halford JC; Nunes de Souza RL; Canto de Souza AL; Piper DC; Arch JR; Upton N; Porter RA; Johns A; Blundell JE
Eur J Neurosci; 2001 Apr; 13(7):1444-52. PubMed ID: 11298806
[TBL] [Abstract][Full Text] [Related]
46. Orexin A modulates neuronal activity of the rodent suprachiasmatic nucleus in vitro.
Klisch C; Inyushkin A; Mordel J; Karnas D; Pévet P; Meissl H
Eur J Neurosci; 2009 Jul; 30(1):65-75. PubMed ID: 19519637
[TBL] [Abstract][Full Text] [Related]
47. NERP-2 regulates gastric acid secretion and gastric emptying via the orexin pathway.
Namkoong C; Toshinai K; Waise TMZ; Sakoda H; Sasaki K; Ueta Y; Kim MS; Minamino N; Nakazato M
Biochem Biophys Res Commun; 2017 Apr; 485(2):409-413. PubMed ID: 28213131
[TBL] [Abstract][Full Text] [Related]
48. The effect of porcine Orexin A on insulin plasma concentrations in pigs.
Papakonstantinou P; Tziris N; Kesisoglou I; Gotzamani-Psarrakou A; Tsonidis C; Patsikas MN; Papazoglou LG
J Biol Regul Homeost Agents; 2007; 21(3-4):115-24. PubMed ID: 18261263
[TBL] [Abstract][Full Text] [Related]
49. Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation.
Silveyra P; Lux-Lantos V; Libertun C
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E977-85. PubMed ID: 17638707
[TBL] [Abstract][Full Text] [Related]
50. The role of orexin A in the control of prolactin and growth hormone secretions in sheep--in vitro study.
Molik E; Zieba DA; Misztal T; Romanowicz K; Wszola M; Wierzchos E; Nowakowski M
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():91-100. PubMed ID: 19261974
[TBL] [Abstract][Full Text] [Related]
51. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat.
Dugovic C; Shelton JE; Aluisio LE; Fraser IC; Jiang X; Sutton SW; Bonaventure P; Yun S; Li X; Lord B; Dvorak CA; Carruthers NI; Lovenberg TW
J Pharmacol Exp Ther; 2009 Jul; 330(1):142-51. PubMed ID: 19363060
[TBL] [Abstract][Full Text] [Related]
52. I.c.v. administration of orexin-A induces an antidepressive-like effect through hippocampal cell proliferation.
Ito N; Yabe T; Gamo Y; Nagai T; Oikawa T; Yamada H; Hanawa T
Neuroscience; 2008 Dec; 157(4):720-32. PubMed ID: 18952152
[TBL] [Abstract][Full Text] [Related]
53. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
Rasmussen K; Hsu MA; Yang Y
Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
[TBL] [Abstract][Full Text] [Related]
54. Arousal effects of orexin A on acute alcohol intoxication-induced coma in rats.
Jia X; Yan J; Xia J; Xiong J; Wang T; Chen Y; Qi A; Yang N; Fan S; Ye J; Hu Z
Neuropharmacology; 2012 Feb; 62(2):775-83. PubMed ID: 21924278
[TBL] [Abstract][Full Text] [Related]
55. Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.
Li Y; Wang H; Qi K; Chen X; Li S; Sui N; Kirouac GJ
Physiol Behav; 2011 Jan; 102(1):42-50. PubMed ID: 20951152
[TBL] [Abstract][Full Text] [Related]
56. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat.
Sibilia V; Muccioli G; Deghenghi R; Pagani F; De Luca V; Rapetti D; Locatelli V; Netti C
J Neuroendocrinol; 2006 Feb; 18(2):122-8. PubMed ID: 16420281
[TBL] [Abstract][Full Text] [Related]
57. Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system.
Shiuchi T; Haque MS; Okamoto S; Inoue T; Kageyama H; Lee S; Toda C; Suzuki A; Bachman ES; Kim YB; Sakurai T; Yanagisawa M; Shioda S; Imoto K; Minokoshi Y
Cell Metab; 2009 Dec; 10(6):466-80. PubMed ID: 19945404
[TBL] [Abstract][Full Text] [Related]
58. [Orexins and pain processing].
Yamamoto T; Shono K
Masui; 2007 Jan; 56(1):40-7. PubMed ID: 17243644
[TBL] [Abstract][Full Text] [Related]
59. Regulation of food intake in the goldfish by interaction between ghrelin and orexin.
Miura T; Maruyama K; Shimakura S; Kaiya H; Uchiyama M; Kangawa K; Shioda S; Matsuda K
Peptides; 2007 Jun; 28(6):1207-13. PubMed ID: 17481778
[TBL] [Abstract][Full Text] [Related]
60. Reinvestigation of the effect of orexin A on catecholamine release from adrenal chromaffin cells.
Chen XW; Huang W; Yan JA; Fan HX; Guo N; Lü J; Xiu Y; Gu JL; Zhang CX; Ruan HZ; Hu ZA; Yu ZP; Zhou Z
Neurosci Lett; 2008 May; 436(2):181-4. PubMed ID: 18395341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]